CLINICAL_TRIALS
research
· 2024-09-20
Clinical Trial Update: Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD) [NA]
Summary
This clinical trial is evaluating the efficacy and safety of Calculus Bovis Sativus (CBS) for idiopathic inflammatory demyelinating diseases, including multiple…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tongji Hospital | Conditions: Idiopathic Inflammatory Demyelinating Disease, Multiple Sclerosis | NA | Status: RECRUITING